Interesting - so what does this say about Sarepta’s Gene Therapy program?
Someone at Sarepta must have photos of FDA staff - how on earth did FDA approve Sarepta given the functional results!
PER is in a good place now on the combination therapy front, but question remains if one of the big Gorilla’s will want it all to themselves?
Great 6 months ahead - hopefully with real value accretion.
.
per-chart, page-840
-
- There are more pages in this discussion • 217 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
